Phase I Clinical Trial of Everolimus Combined with Trimodality Therapy in Patients with Muscle-Invasive Bladder Cancer

Bassel G. Bachir; Luis Souhami; Jose João Mansure; Fabio Cury; Marie Vanhuyse; Fadi Brimo; Armen G. Aprikian; Simon Tanguay; Jeremy Sturgeon; Wassim Kassouf

doi:10.3233/blc-160090

Phase I Clinical Trial of Everolimus Combined with Trimodality Therapy in Patients with Muscle-Invasive Bladder Cancer

Bladder Cancer ◽

10.3233/blc-160090 ◽

2017 ◽

Vol 3 (2) ◽

pp. 105-112 ◽

Cited By ~ 3

Author(s):

Bassel G. Bachir ◽

Luis Souhami ◽

Jose João Mansure ◽

Fabio Cury ◽

Marie Vanhuyse ◽

...

Keyword(s):

Clinical Trial ◽

Bladder Cancer ◽

Phase I ◽

Phase I Clinical Trial ◽

Invasive Bladder Cancer ◽

Muscle Invasive Bladder Cancer ◽

Trimodality Therapy ◽

Muscle Invasive

Download Full-text

Results of a phase I/II single arm clinical trial assessing efficacy, safety and tolerability of the recombinant Bacillus Calmette Guérin VPM1002BC in patients with non-muscle invasive bladder cancer recurrence after BCG induction with or without BCG maintenance therapy – SAKK 06/14

Urologic Oncology Seminars and Original Investigations ◽

10.1016/j.urolonc.2020.10.027 ◽

2020 ◽

Vol 38 (12) ◽

pp. 898

Author(s):

Cyrill A Rentsch ◽

George N Thalmann ◽

Ilaria Lucca ◽

Maciej Kwiatkowski ◽

Grégory J Wirth ◽

...

Keyword(s):

Clinical Trial ◽

Bladder Cancer ◽

Maintenance Therapy ◽

Phase I ◽

Cancer Recurrence ◽

Invasive Bladder Cancer ◽

Bacillus Calmette Guerin ◽

Muscle Invasive Bladder Cancer ◽

Muscle Invasive ◽

Bladder Cancer Recurrence

Download Full-text

Results of the phase-I open-label clinical trial SAKK 06/14 assessing safety of intravesical instillation of the recombinant BCG VPM1002BC in patients with non-muscle invasive bladder cancer and previous failure to conventional BCG therapy

European Urology Supplements ◽

10.1016/s1569-9056(18)31563-x ◽

2018 ◽

Vol 17 (2) ◽

pp. e1050 ◽

Cited By ~ 5

Author(s):

C. Rentsch ◽

P. Bosshard ◽

G. Mayor ◽

M. Rieken ◽

H. Püschel ◽

...

Keyword(s):

Clinical Trial ◽

Bladder Cancer ◽

Phase I ◽

Intravesical Instillation ◽

Invasive Bladder Cancer ◽

Open Label ◽

Muscle Invasive Bladder Cancer ◽

Bcg Therapy ◽

Muscle Invasive ◽

Recombinant Bcg

Download Full-text

Results of the phase I open label clinical trial SAKK 06/14 assessing safety of intravesical instillation of VPM1002BC, a recombinant mycobacterium Bacillus Calmette Guérin (BCG), in patients with non-muscle invasive bladder cancer and previous failure of conventional BCG therapy

OncoImmunology ◽

10.1080/2162402x.2020.1748981 ◽

2020 ◽

Vol 9 (1) ◽

pp. 1748981 ◽

Cited By ~ 3

Author(s):

Cyrill A. Rentsch ◽

Piet Bosshard ◽

Grégoire Mayor ◽

Malte Rieken ◽

Heike Püschel ◽

...

Keyword(s):

Clinical Trial ◽

Bladder Cancer ◽

Phase I ◽

Intravesical Instillation ◽

Invasive Bladder Cancer ◽

Bacillus Calmette Guerin ◽

Open Label ◽

Muscle Invasive Bladder Cancer ◽

Bcg Therapy ◽

Muscle Invasive

Download Full-text

Faculty Opinions recommendation of Intravesical nadofaragene firadenovec gene therapy for BCG-unresponsive non-muscle-invasive bladder cancer: a single-arm, open-label, repeat-dose clinical trial.

Faculty Opinions – Post-Publication Peer Review of the Biomedical Literature ◽

10.3410/f.739122585.793581022 ◽

2020 ◽

Author(s):

Otto Hemminki

Keyword(s):

Clinical Trial ◽

Gene Therapy ◽

Bladder Cancer ◽

Invasive Bladder Cancer ◽

Repeat Dose ◽

Open Label ◽

Muscle Invasive Bladder Cancer ◽

Muscle Invasive

Download Full-text

A phase I open label dose‐escalation study to evaluate the tolerability, safety and immunological efficacy of sub‐urothelial durvalumab injection in adults with muscle‐invasive or high‐risk non‐muscle‐invasive bladder cancer (SUBDUE‐1, SUB‐urothelial DUrvalumab injection‐1 study): clinical trial protocol

BJU International ◽

10.1111/bju.15365 ◽

2021 ◽

Author(s):

Andrew Moe ◽

Elizabeth Liow ◽

Andrew Redfern ◽

Nicole Swarbrick ◽

Tom Ferguson ◽

...

Keyword(s):

Clinical Trial ◽

Bladder Cancer ◽

High Risk ◽

Phase I ◽

Trial Protocol ◽

Open Label ◽

Muscle Invasive Bladder Cancer ◽

Dose Escalation Study ◽

Label Dose ◽

Muscle Invasive

Download Full-text

The effect of a neoadjuvant instillation of chemotherapy in the prevention of recurrences of non-muscle invasive bladder cancer. Preliminary results of the PRECAVE prospective, controlled, randomized clinical trial

European Urology ◽

10.1016/s0302-2838(21)01132-5 ◽

2021 ◽

Vol 79 ◽

pp. S1043-S1044

Author(s):

D.M. Carrión Monsalve ◽

J. Gomez Rivas ◽

C.R. Trelles ◽

C. Ballesteros Ruiz ◽

M. Alvarez-Maestro ◽

...

Keyword(s):

Clinical Trial ◽

Bladder Cancer ◽

Randomized Clinical Trial ◽

Invasive Bladder Cancer ◽

Muscle Invasive Bladder Cancer ◽

Preliminary Results ◽

Muscle Invasive

Download Full-text

Diagnostic performance of the Bladder EpiCheck methylation test and photodynamic diagnosis-guided cystoscopy in the surveillance of high-risk non-muscle invasive bladder cancer: A single centre, prospective, blinded clinical trial

Urologic Oncology Seminars and Original Investigations ◽

10.1016/j.urolonc.2021.11.001 ◽

2021 ◽

Author(s):

Giovanni Cochetti ◽

Jacopo Adolfo Rossi de Vermandois ◽

Vincenza Maulà ◽

Luigi Cari ◽

Rosy Cagnani ◽

...

Keyword(s):

Clinical Trial ◽

Bladder Cancer ◽

High Risk ◽

Diagnostic Performance ◽

Invasive Bladder Cancer ◽

Photodynamic Diagnosis ◽

Single Centre ◽

Muscle Invasive Bladder Cancer ◽

Muscle Invasive

Download Full-text

The benefit of a neoadjuvant instillation of chemotherapy in non-muscle invasive bladder cancer: interim analysis of the PRECAVE randomized clinical trial.

10.37554/en-j.arch.esp.urol-20210704-3511-30 ◽

2021 ◽

Author(s):

Diego Carrión ◽

Juan Gómez Rivas ◽

Cristina Ballesteros Ruiz ◽

Mario Álvarez-Maestro ◽

Emilio Ríos González ◽

...

Keyword(s):

Clinical Trial ◽

Bladder Cancer ◽

Randomized Clinical Trial ◽

Interim Analysis ◽

Invasive Bladder Cancer ◽

Muscle Invasive Bladder Cancer ◽

Muscle Invasive

Download Full-text

Subtyping Muscle-Invasive Bladder Cancer to Assess Clinical Response to Trimodality Therapy

International Journal of Radiation Oncology*Biology*Physics ◽

10.1016/j.ijrobp.2017.06.278 ◽

2017 ◽

Vol 99 (2) ◽

pp. S118 ◽

Cited By ~ 1

Author(s):

J.A. Efstathiou ◽

E. Gibb ◽

D.T. Miyamoto ◽

C.L. Wu ◽

M.R. Drumm ◽

...

Keyword(s):

Bladder Cancer ◽

Clinical Response ◽

Invasive Bladder Cancer ◽

Muscle Invasive Bladder Cancer ◽

Trimodality Therapy ◽

Muscle Invasive

Download Full-text

Adjuvant recMAGE-A3 Immunotherapy After Cystectomy for Muscle-invasive Bladder Cancer: Lessons Learned from the Phase 2 MAGNOLIA Clinical Trial

European Urology Focus ◽

10.1016/j.euf.2018.02.005 ◽

2019 ◽

Vol 5 (5) ◽

pp. 849-852

Author(s):

Peter F.A. Mulders ◽

Luis Martínez-Piñeiro ◽

Axel Heidenreich ◽

Marko Babjuk ◽

Marc Colombel ◽

...

Keyword(s):

Clinical Trial ◽

Bladder Cancer ◽

Lessons Learned ◽

Invasive Bladder Cancer ◽

Phase 2 ◽

Muscle Invasive Bladder Cancer ◽

Muscle Invasive

Download Full-text